Therapeutic Profile of Human Umbilical Cord Blood Serum and Autologous Serum Therapies in Treatment of Ocular Surface Disorders: A Pilot Study
Journal of Ocular Pharmacology and Therapeutics · 01.02.2023 · 39 (1) · 36-47
DOI: 10.1089/jop.2022.0107 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, online erschienen am 25.01.2023. Verfasst von Akhilesh Kumar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Gandhi Medical College, Bhopal, India. Hauptthemen laut MEDLINE: Fetal Blood, Dry Eye Syndromes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Purpose
Umbilical cord blood serum (UCBS) is an effective adjunctive treatment along with conventional therapy in ocular surface disorders (OSDs). It aids in rapid ocular surface restoration thereby achieving epithelial integrity, in addition to improvement in subjective and objective parameters. The study aims to compare the efficacy of human umbilical cord blood serum and autologous serum (AS) in treatment of OSD.
Methods
A prospective randomized study was conducted on 101 eyes diagnosed with OSD resulting from dry eye disease (DED; n = 40), acute chemical burn (ACB; n = 21), and ocular allergy (OA; n = 40). Randomization was done in Group I, administered with AS, and Group II with UCBS. Outcomes evaluated were visual acuity (VA), eye sensation score (ESS), ocular surface disease index (OSDI), tear break-up time (TBUT), Schirmer's value, Corneal Fluorescein Score, epithelial defect, limbal ischemia, corneal clarity (CC), and improvement in grade of severity. Statistical analysis was done using Wilcoxon signed-rank, Wilcoxon rank sum, Chi-square, and Z -test with a significance level ( P ≤ 0.05).
Results
In DED, Group II showed significant improvement in VA, ESS, and OSDI by the 7th day, whereas the mean Schirmer, TBUT, and corneal fluorescein staining score improved by 3 months. In ACB, Group II showed improvement in VA, reepithelialization, reduction in limbal ischemia, and CC by 3 months. In OA, Group II showed improvement in ESS by day 7.
Conclusion
Human umbilical cord blood serum is more effective than AS in restoring ocular surface.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Gandhi Medical College, Bhopal, India.
- Department of Microbiology, Gandhi Medical College, Bhopal, India.
- Department of Obstetrics and Gynecology, Gandhi Medical College, Bhopal, India.
- Department of Ophthalmology, All India Institute of Medical Sciences, Bhopal, India.
- Department of Ophthalmology, College of Veterinary Medicine, Surgery and Mason Eye Institute, University of Missouri, Columbia, Missouri, USA.
ORCID-Profile: Deepak Soni, Rajiv R Mohan
Zitieren
APA
Kumar, A., Chaurasiya, D., Sultan, S., Soni, D., Kubrey, S., Singh, P., Verma, S., Mohan, R. R., & Sharma, B. (2023). Therapeutic Profile of Human Umbilical Cord Blood Serum and Autologous Serum Therapies in Treatment of Ocular Surface Disorders: A Pilot Study. Journal of Ocular Pharmacology and Therapeutics, 39(1), 36-47. https://doi.org/10.1089/jop.2022.0107
Vancouver
Kumar A, Chaurasiya D, Sultan S, Soni D, Kubrey S, Singh P, et al. Therapeutic Profile of Human Umbilical Cord Blood Serum and Autologous Serum Therapies in Treatment of Ocular Surface Disorders: A Pilot Study. Journal of Ocular Pharmacology and Therapeutics. 2023;39(1):36-47. doi:10.1089/jop.2022.0107
BibTeX
@article{Kumar2023,
author = {Kumar, Akhilesh and Chaurasiya, Deepti and Sultan, Shabana and Soni, Deepak and Kubrey, Suraj and Singh, Priti and Verma, Sunil and Mohan, Rajiv R and Sharma, Bhavana},
title = {Therapeutic Profile of Human Umbilical Cord Blood Serum and Autologous Serum Therapies in Treatment of Ocular Surface Disorders: A Pilot Study},
journal = {Journal of Ocular Pharmacology and Therapeutics},
year = {2023},
volume = {39},
number = {1},
pages = {36--47},
doi = {10.1089/jop.2022.0107}
}
EUVIMED